In recent years, the prevalence of chronic diseases has risen dramatically. Diabetes, osteoporosis, cardiovascular disease (CVD), and multiple sclerosis all necessitate the administration of injectable drugs on a daily or weekly basis. Because chronic diseases require frequent medicine delivery, injector pens are the best alternative. For injectable medicine delivery devices, injection pens have become the new norm.
Inadequate training and teaching for the use of innovative
delivery methods such as injectable pens leads to incorrect use, which puts
personnel and patients at risk. Such methods may have an impact on the use of
injectable pens in hospitals. Between January 2013 and June 2019, the National
Reporting and Learning System (NRLS, UK) documented 56 events involving insulin
withdrawal from insulin pens or refill cartridges. Furthermore, because the
strength of insulin in the injection pen varies, there is a risk of overdosing
if the dose strength is not taken into account. Another issue is the reusing of
insulin pens. This injection
pen market report covers recent developments, trade regulations,
import-export analysis, production analysis, value chain optimization, market
share, the impact of domestic and localised market players, emerging revenue
pockets, changes in market regulations, and strategic market growth analysis.
Medicine is injected into the human body using injection
pens. They are used to inject the patient with insulin. Patients can stick to
their treatment plans with the help of injection pens. This method has aided in
enhancing the patient's quality of life while also lowering healthcare costs.
Medical supplies are in high demand to care for the afflicted
populace. In primary clinical treatment, respiratory support equipment such as
an atomizer, a life-support machine, an oxygen generator, and a monitor are
among the most commonly used medical devices.